WallStreetZenWallStreetZen

NASDAQ: APDN
Applied Dna Sciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their APDN stock forecasts and price targets.

Forecast return on equity

Is APDN forecast to generate an efficient return?

Company
N/A
Industry
-0.55%
Market
67.42%

Forecast return on assets

Is APDN forecast to generate an efficient return on assets?

Company
N/A
Industry
12.51%

APDN earnings per share forecast

What is APDN's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$652.47

APDN revenue forecast

What is APDN's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$3.4M-10.3%
APDN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

APDN revenue growth forecast

How is APDN forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
-10.9%
Industry
5.17%
Market
9.84%
APDN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
APDN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

APDN vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
APDN$4.68N/AN/A
NDRA$3.45$46.00+1,233.33%Buy
ISPC$1.06N/AN/A
MYNZ$1.83$14.00+665.03%Strong Buy
CHEK$0.74N/AN/A
View Top Diagnostic & Research Stocks

Applied Dna Sciences Stock Forecast FAQ

What is APDN's earnings growth forecast for 2025-2025?

(NASDAQ: APDN) Applied Dna Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 23.18%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.73%.

Applied Dna Sciences's earnings in 2025 is -$46,187,186.

In 2025, APDN is forecast to generate -$282,639,743 in earnings, with the lowest earnings forecast at -$282,639,743 and the highest earnings forecast at -$282,639,743.

If you're new to stock investing, here's how to buy Applied Dna Sciences stock.

What is APDN's revenue growth forecast for 2025-2025?

(NASDAQ: APDN) Applied Dna Sciences's forecast annual revenue growth rate of -10.9% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.84%.

Applied Dna Sciences's revenue in 2025 is $3,790,617.

In 2025, APDN is forecast to generate $1,472,832 in revenue, with the lowest revenue forecast at $1,472,832 and the highest revenue forecast at $1,472,832.

What is APDN's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: APDN) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 12.51%.

What is APDN's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: APDN) Applied Dna Sciences's current Earnings Per Share (EPS) is -$50.25. In 2025, APDN's EPS is forecast to hit -$652.47 (min: -$652.47, max: -$652.47).

What is APDN's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: APDN) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.